Emergent BioSolutions Inc (EBS) insider trading
Every open-market stock purchase and sale by Emergent BioSolutions Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Donald W DeGolyer (Director) and 1 other sold $146K in the last 90 days.
- Last insider buy: Joseph C Papa (CEO), $350K, 17 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $1.3M (11 sales). Last close $6.20 on Oct 21, 2026.
Recent EBS insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 7, 2026 | Donald W DeGolyer (Director) | Sold | $126K |
| Oct 1, 2026 | Paul Anthony Williams (VP) | Sold | $19.6K |
| Jul 1, 2026 | Paul Anthony Williams (VP) | Sold | $25.2K |
| Jun 8, 2026 | Richard S Lindahl (CFO) | Sold (not open market) | $31.7K |
| Jun 8, 2026 | Coleen Glessner (VP) | Sold (not open market) | $16.1K |
| Jun 8, 2026 | William Hartzel (VP) | Sold (not open market) | $13.9K |
| Jun 8, 2026 | Paul Anthony Williams (VP) | Sold (not open market) | $5.6K |
| May 1, 2026 | Kathryn C Zoon (Director) | Sold | $135K |
| May 1, 2026 | Donald W DeGolyer (Director) | Sold | $121K |
| May 1, 2026 | Sujata Tyagi Dayal (Director) | Sold | $107K |
| May 1, 2026 | Kathryn C Zoon (Director) | Sold | $9.5K |
| May 1, 2026 | Sujata Tyagi Dayal (Director) | Sold | $8.8K |
| May 1, 2026 | Donald W DeGolyer (Director) | Sold | $8.5K |
| Apr 30, 2026 | Keith Katkin (Director) | Sold | $128K |
| Apr 30, 2026 | Kathryn C Zoon (Director) | Bought (not open market) | — |
| Apr 30, 2026 | John D Fowler Jr (Director) | Bought (not open market) | — |
| Apr 30, 2026 | Neal Franklin Fowler (Director) | Bought (not open market) | — |
| Apr 30, 2026 | Keith Katkin (Director) | Bought (not open market) | — |
| Apr 30, 2026 | Kathryn C Zoon (Director) | Bought (not open market) | — |
| Apr 30, 2026 | Sujata Tyagi Dayal (Director) | Bought (not open market) | — |
| Apr 30, 2026 | Sujata Tyagi Dayal (Director) | Bought (not open market) | — |
| Apr 30, 2026 | Donald W DeGolyer (Director) | Bought (not open market) | — |
| Apr 30, 2026 | Donald W DeGolyer (Director) | Bought (not open market) | — |
| Apr 30, 2026 | John D Fowler Jr (Director) | Bought (not open market) | — |
| Apr 30, 2026 | Keith Katkin (Director) | Bought (not open market) | — |
Who's trading EBS
- Donald W DeGolyer, Director: sold $444K (4 sales), last Oct 7, 2026
- Paul Anthony Williams, VP: sold $78.5K (3 sales), last Oct 1, 2026
- Coleen Glessner, VP: other filings, last Jun 8, 2026
- Richard S Lindahl, CFO: other filings, last Jun 8, 2026
- William Hartzel, VP: other filings, last Jun 8, 2026
- Kathryn C Zoon, Director: sold $144K (2 sales), last May 1, 2026
- Sujata Tyagi Dayal, Director: sold $201K (3 sales), last May 1, 2026
- Zsolt Harsanyi, Chair: other filings, last Apr 30, 2026
- Keith Katkin, Director: sold $128K (1 sale), last Apr 30, 2026
- Neal Franklin Fowler, Director: other filings, last Apr 30, 2026
- Ronald Richard, Director: sold $263K (2 sales), last Apr 30, 2026
- Marvin L White, Director: other filings, last Apr 30, 2026
- John D Fowler Jr, Director: other filings, last Apr 30, 2026
- Simon C Lowry, C-suite exec: other filings, last Apr 29, 2026
- Joseph C Papa, CEO: other filings, last Apr 29, 2026
Get free alerts when an insider at Emergent BioSolutions Inc files a new trade →